According to SurgePays's latest financial reports the company's current revenue (TTM) is $0.13 B. In 2022 the company made a revenue of $0.12 B an increase over the years 2021 revenue that were of $51.06 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.13 B | 12.83% |
2022 | $0.12 B | 138.04% |
2021 | $51.06 M | -6.15% |
2020 | $54.4 M | 111.35% |
2019 | $25.74 M | 68.87% |
2018 | $15.24 M | 966.12% |
2017 | $1.42 M | -56.63% |
2016 | $3.29 M | 79.52% |
2015 | $1.83 M | 90946.8% |
2014 | $0 M | 20.06% |
2013 | $0 M | 12.37% |
2012 | $0 M | -28.19% |
2011 | $0 M | -85.93% |
2010 | $0.01 M | 53.74% |
2009 | $0 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $89.65 B | 65,276.84% | ๐บ๐ธ USA |
Novartis NVS | $49.92 B | 36,303.19% | ๐จ๐ญ Switzerland |
Stryker Corporation SYK | $20.96 B | 15,185.64% | ๐บ๐ธ USA |
Cooper Companies COO | $3.66 B | 2,573.36% | ๐บ๐ธ USA |
STAAR Surgical STAA | $0.32 B | 135.10% | ๐บ๐ธ USA |
CONMED CNMD | $1.26 B | 819.89% | ๐บ๐ธ USA |
Integra LifeSciences IART | $1.54 B | 1,024.07% | ๐บ๐ธ USA |